Securities code: 002589 securities abbreviation: Realcan Pharmaceutical Group Co.Ltd(002589) Announcement No.: 2022-015
Realcan Pharmaceutical Group Co.Ltd(002589)
Announcement on the pledge of some shares of the actual controller
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records and misleading
Statements or material omissions.
Realcan Pharmaceutical Group Co.Ltd(002589) (hereinafter referred to as “the company”) recently received a letter from Han Xuxian, the actual controller
According to the letter from Ms. Sheng and Ms. Zhang Renhua, the actual controller received the China securities registration on February 21, 2022
The registration certificate of share pledge of Clearing Co., Ltd. shows that some shares of the company held by it have been pledged. The specific matters are as follows: I. Basic information of this pledge
Whether it is the controlling shareholder of the company, whether the share shareholder or pledge accounts for the total of its company, whether it is limited to the largest number of shares in the name of supplementary pledge and pledge, and whether the share capital held by the company is sold and pledged from the beginning to the pledgee’s use East and one (10000 proportion pledge date Tuzhi action person shares) day
Jingzhou recruitment
2022 shanghuize compensation executives locked in February, pharmaceutical returned Han Xu to 1000 5.33% 0.66% shares, no month 16 – invested in the partnership business on the bond day (limited)
Partnership)
Jingzhou recruitment
2022 Shang Huize reimburses Zhang Ren’s senior executives. In February, the pharmaceutical returned to China was 10000 36.63% and 6.65% shares. No month 18 – invested in the partnership business on the bond day (limited)
Partnership)
Total – 11000 23.89% 7.31%——————
The Pledged Shares do not involve the performance compensation obligation of major asset restructuring. II. The cumulative pledge of shares held by shareholders
As of the disclosure date of the announcement, the Pledged Shares held by Mr. Han Xu, Ms. Zhang Renhua and those acting in concert
As follows:
The Pledged Shares, the Pledged Shares, the shares held by the shareholders, the number of shares held by the shareholders, the proportion of the accumulated pledged shares before and after the pledge in the Pledged Shares and the unsecured shares of the company
Name (10000 shares) case cumulative pledge pledge amount pledge amount total shares held shares subject to sale restriction and proportion in pledged shares subject to sale restriction and proportion in non quality (10000 shares) (10000 shares) frozen amount pledge shares frozen amount pledge shares (10000 shares) Proportion (10000 shares)
Zhang Renhua 27296.8159 18.14% 16641.2687 26641.2687 97.60% 17.71% 19881.2618 74.63% 591.3501 90.21%
Han Xu 18749.1897 12.46% 8920.5474 9920.5474 52.91% 6.59% 6507.2500 65.59% 7554.6423 85.57%
Total 46046.0056 30.60% 25561.8124 36561.8161 79.40% 24.30% 26388.5118 72.18% 8145.9924 85.89%
3、 Share pledge of controlling shareholders and persons acting in concert
(1) This share pledge financing does not involve meeting the relevant needs of the production and operation of the listed company.
(2) Cumulative number of pledged shares due in the next six months and one year for Mr. Han Xu and Ms. Zhang Renhua
234481661 shares, accounting for 50.92% of its shares and 15.58% of the total share capital of the company;
The financing balance in the next six months will be 17 million yuan, and the financing balance in the next year will be 283.59 million yuan. Mr. Han Xu
Ms. Zhang Renhua’s repayment funds mainly come from her own and self raised funds, which has sufficient capital repayment ability
power.
(3) The controlling shareholders and their persons acting in concert do not have any infringement such as occupation of non operating funds and illegal guarantee
The interests of listed companies.
(4) The share pledge will not affect the operation and corporate governance of the listed company
The actual controllers, Mr. Han Xu and Ms. Zhang Renhua, are in good credit status and have good capital repayment ability. They are not allowed to
There are situations that may lead to liquidation or forced liquidation, and there is no situation that may lead to the actual control of the company
Substantive factors of change. In case of subsequent risks, measures will be taken, including but not limited to supplementary pledge and prepayment
And other measures. In case of other major changes in the above pledge matters, the company will comply with relevant regulations
It shall be disclosed in a timely manner.
4、 Documents for future reference
1. Registration certificate of share pledge
2. Details of share freeze of China Securities Depository and Clearing Corporation Limited
Realcan Pharmaceutical Group Co.Ltd(002589)
Board of directors
February 23, 2022
